Microbiological aspects of dysbiosis in infertility and miscarriage of pregnancy and their correction

Authors: N. Silina, G. Koval, T. Silina, V. Berezhnoy, Yu. Nesterova


Growth of inflammatory diseases of woman’s sexual sphere depends on TSI and microorganisms from normal ecosystem of vagina.

A purpose of trial was investigation of microbiocenosis for 56 patients of genesial age, which were in pregravidarnom period. 19 from them in anamnesis had correction unmaturing of pregnancy. All women got Breveluck (World Medicine) for to a 1 capsule 3 times per a day during 2 weeks in 2-d phase of menstrual – ovarian cycle, two cycles. In 2 months of therapy only 3 patients have excretions from vagina with pH level of 5,3–5,5. Other patients don’t have any excretion. The bacteri- al investigation showed lactobacillus in vaginal excretion with pH level of 4,46±0,1.

Due to high therapeutic efficiency of probiotic Breveluck it is possible to recommend in complex and monotherapies.

Key words: microbiocenosis of vagina, treatment, prophylaxis, probiotik Breveluck.

Published in the journal “Women’s Health” №10 (126) ‘2017

ARTICLES FROM CATEGORY
Support of educational events. Participation of World Medicine in the First Congress of Optometrists of Ukraine.
Cetirizine is an effective and safe antihistamine (literature review, results of clinical researches)
All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024"

PROVE YOU ARE A MEDICAL PROFESSIONAL

Attention: This section is intended for healthcare professionals only. If you are not a medical professional, you can return to the main page by clicking the “No” option

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design